Hybio Pharmaceutical (300199) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.177x

Based on the latest financial reports, Hybio Pharmaceutical (300199) has a cash flow conversion efficiency ratio of 0.177x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.78 Million ≈ $17.23 Million USD) by net assets (CN¥666.08 Million ≈ $97.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hybio Pharmaceutical market cap and net worth for the company's overall valuation and market capitalisation.

Hybio Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Hybio Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hybio Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hybio Pharmaceutical ranked by their cash flow conversion efficiency. Explore Hybio Pharmaceutical (300199) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Robotis Co.Ltd KQ:108490	-0.005x
Shanghai Daimay Auto Interior SHG:603730	0.049x
Changzhou Xingyu Automotive Lighting Systems Co Ltd SHG:601799	0.059x
PENNON GROUP PLC UNS.ADR2 F:3PN0	N/A
Knowles Cor NYSE:KN	0.035x
XJ Electric Co Ltd SHE:000400	0.059x
Veidekke ASA OL:VEI	0.397x
Orion Oyj A HE:ORNAV	0.086x

Annual Cash Flow Conversion Efficiency for Hybio Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Hybio Pharmaceutical from 2007 to 2024. View 300199 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥597.05 Million ≈ $87.37 Million	CN¥164.71 Million ≈ $24.10 Million	0.276x	+6209.36%
2023-12-31	CN¥783.21 Million ≈ $114.61 Million	CN¥-3.54 Million ≈ $-517.51K	-0.005x	-137.05%
2022-12-31	CN¥1.30 Billion ≈ $189.78 Million	CN¥15.81 Million ≈ $2.31 Million	0.012x	-87.19%
2021-12-31	CN¥1.65 Billion ≈ $241.15 Million	CN¥156.83 Million ≈ $22.95 Million	0.095x	+232.72%
2020-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥47.99 Million ≈ $7.02 Million	0.029x	-38.96%
2019-12-31	CN¥2.23 Billion ≈ $326.77 Million	CN¥104.64 Million ≈ $15.31 Million	0.047x	+238.15%
2018-12-31	CN¥3.39 Billion ≈ $496.31 Million	CN¥47.00 Million ≈ $6.88 Million	0.014x	-74.81%
2017-12-31	CN¥3.88 Billion ≈ $568.47 Million	CN¥213.74 Million ≈ $31.28 Million	0.055x	-33.09%
2016-12-31	CN¥3.60 Billion ≈ $527.46 Million	CN¥296.41 Million ≈ $43.37 Million	0.082x	+56.20%
2015-12-31	CN¥2.64 Billion ≈ $385.92 Million	CN¥138.84 Million ≈ $20.32 Million	0.053x	-55.53%
2014-12-31	CN¥1.30 Billion ≈ $189.67 Million	CN¥153.43 Million ≈ $22.45 Million	0.118x	-13.29%
2013-12-31	CN¥1.12 Billion ≈ $164.51 Million	CN¥153.48 Million ≈ $22.46 Million	0.137x	+59.09%
2012-12-31	CN¥1.02 Billion ≈ $148.68 Million	CN¥87.19 Million ≈ $12.76 Million	0.086x	+15.57%
2011-12-31	CN¥976.09 Million ≈ $142.83 Million	CN¥72.48 Million ≈ $10.61 Million	0.074x	-75.48%
2010-12-31	CN¥180.59 Million ≈ $26.43 Million	CN¥54.69 Million ≈ $8.00 Million	0.303x	+48.18%
2009-12-31	CN¥127.74 Million ≈ $18.69 Million	CN¥26.11 Million ≈ $3.82 Million	0.204x	-55.67%
2008-12-31	CN¥99.23 Million ≈ $14.52 Million	CN¥45.75 Million ≈ $6.69 Million	0.461x	-54.21%
2007-12-31	CN¥48.70 Million ≈ $7.13 Million	CN¥49.04 Million ≈ $7.18 Million	1.007x	--

About Hybio Pharmaceutical

SHE:300199 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.04 Billion

CN¥20.76 Billion CNY

Market Cap Rank

#4912 Global

#839 in China

Share Price

CN¥23.50

Change (1 day)

-0.63%

52-Week Range

CN¥16.36 - CN¥26.52

All Time High

CN¥29.95